Not many dividend stocks can boast the diversification, growth opportunities, and solid balance sheet of health-care company Johnson & Johnson (NYSE: JNJ ) . With products ranging from consumer goods, like Band-Aids, to cutting-edge drugs for the treatment of prostate cancer, Johnson & Johnson is an attractive stock to dividend investors. In this video, from the Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso discuss reasons to be bullish about Johnson & Johnson.
Looking for more dividend stocks?
One of the best parts of owning big pharma stocks like Johnson & Johnson is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.
The relevant video segment can be found between 7:52 and 9:51.